Shopping Cart

Remove All

Your shopping cart is currently empty

Proceed to checkout Continue shopping

Pomalidomide-PEG3-C2-NH2 (TFA)

Name: Pomalidomide-PEG3-C2-NH2 (TFA)
Brand: TargetMol
SKU: T17882
Rating: 4.5 (1 reviews)

😃Good

Catalog No. T17882

Alias Pomalidomide-PEG3-C2-NH2 (TFA) (2093416-31-8 free base), E3 ligase Ligand-Linker Conjugates 30 (TFA), Cereblon Ligand-Linker Conjugates 5 (TFA)

Pomalidomide-PEG3-C2-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based cereblon ligand and 3-unit PEG linker used in PROTAC technology.

Pomalidomide-PEG3-C2-NH2 (TFA)

😃Good

Catalog No. T17882Alias Pomalidomide-PEG3-C2-NH2 (TFA) (2093416-31-8 free base), E3 ligase Ligand-Linker Conjugates 30 (TFA), Cereblon Ligand-Linker Conjugates 5 (TFA)

Pomalidomide-PEG3-C2-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based cereblon ligand and 3-unit PEG linker used in PROTAC technology.

Pack Size	Price	USA Warehouse	Global Warehouse	Quantity
100 mg	Inquiry	Inquiry	Inquiry
500 mg	Inquiry	Inquiry	Inquiry

Add to Quotation

In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Questions

Resource Download

Product Introduction

Bioactivity

Description	Pomalidomide-PEG3-C2-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based cereblon ligand and 3-unit PEG linker used in PROTAC technology.
Synonyms	Pomalidomide-PEG3-C2-NH2 (TFA) (2093416-31-8 free base), E3 ligase Ligand-Linker Conjugates 30 (TFA), Cereblon Ligand-Linker Conjugates 5 (TFA)

Chemical Properties

Molecular Weight	562.49
Formula	C₂₃H₂₉F₃N₄O₉
Smiles	O=C1N(C(CC2)C(NC2=O)=O)C(C3=C1C=CC=C3NCCOCCOCCOCCN)=O.OC(C(F)(F)F)=O
Relative Density.	no data available

Storage & Solubility Information

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Solubility Information

H2O: 16.67 mg/mL (29.64 mM), Sonication is recommended.

DMSO: 100 mg/mL (177.78 mM), Sonication is recommended.

Solution Preparation Table

H2O/DMSO

	1mg	5mg	10mg	50mg
1 mM	1.7778 mL	8.8890 mL	17.7781 mL	88.8905 mL
5 mM	0.3556 mL	1.7778 mL	3.5556 mL	17.7781 mL
10 mM	0.1778 mL	0.8889 mL	1.7778 mL	8.8890 mL
20 mM	0.0889 mL	0.4445 mL	0.8889 mL	4.4445 mL

DMSO

	1mg	5mg	10mg	50mg
50 mM	0.0356 mL	0.1778 mL	0.3556 mL	1.7778 mL
100 mM	0.0178 mL	0.0889 mL	0.1778 mL	0.8889 mL

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:

For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments

and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent

10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH₂O , the resulting working solution concentration would be 2 mg/mL.

Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSO TargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSO TargetMol | reagent stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH₂O TargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.

All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Pomalidomide-PEG3-C2-NH2 (TFA)Pomalidomide-PEG-3-C2-NH2 (TFA)PomalidomidePEG3C2NH2 (TFA)Pomalidomide-PEG3-C2-NH2Pomalidomide PEG3 C2 NH2 (TFA)E3 ligase Ligand-Linker Conjugates 30Cereblon Ligand-Linker Conjugates 5Cereblon2093416-31-8 free base2093416-31-8

Related Tags: buy Pomalidomide-PEG3-C2-NH2 (TFA) | purchase Pomalidomide-PEG3-C2-NH2 (TFA) | Pomalidomide-PEG3-C2-NH2 (TFA) cost | order Pomalidomide-PEG3-C2-NH2 (TFA) | Pomalidomide-PEG3-C2-NH2 (TFA) chemical structure | Pomalidomide-PEG3-C2-NH2 (TFA) formula | Pomalidomide-PEG3-C2-NH2 (TFA) molecular weight

Pomalidomide-PEG3-C2-NH2 (TFA)

Pomalidomide-PEG3-C2-NH2 (TFA)

Featured Recommendations

Resource Download

Product Introduction

Calculator

In Vivo Formulation Calculator (Clear solution)

Dose Conversion

Tech Support

Keywords